Search alternatives:
linear decrease » linear increase (Expand Search)
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
i large » _ large (Expand Search), a large (Expand Search), i larvae (Expand Search)
linear decrease » linear increase (Expand Search)
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
i large » _ large (Expand Search), a large (Expand Search), i larvae (Expand Search)
-
57341
-
57342
-
57343
-
57344
-
57345
-
57346
-
57347
-
57348
-
57349
-
57350
-
57351
Silencing of IRE1 but not XBP1 downregulates IRF4.
Published 2025“…Annotated are genes decreased 2-fold or more by IRE1 silencing in AMO1 cells (red in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003096#pbio.3003096.g001" target="_blank">Fig 1A</a>). …”
-
57352
-
57353
-
57354
-
57355
-
57356
-
57357
-
57358
-
57359
Image 1_Phage (cocktail)-antibiotic synergism: a new frontier in addressing Klebsiella pneumoniae resistance.tif
Published 2025“…<p>Phages, which play a crucial role in regulating bacterial populations and evolution, have gained renewed attention as potential therapeutic agents especially in the face of rising antimicrobial resistance, such as in Klebsiella pneumoniae– a MDR pathogen with significant clinical implications for immunocompromised individuals. …”
-
57360
Image 5_Phage (cocktail)-antibiotic synergism: a new frontier in addressing Klebsiella pneumoniae resistance.tif
Published 2025“…<p>Phages, which play a crucial role in regulating bacterial populations and evolution, have gained renewed attention as potential therapeutic agents especially in the face of rising antimicrobial resistance, such as in Klebsiella pneumoniae– a MDR pathogen with significant clinical implications for immunocompromised individuals. …”